{"title":"术中应用氨甲环酸治疗青少年特发性脊柱侧凸微创手术的临床效果。","authors":"Jungwook Lim, Rohit Akshay Kavishwar, Joungwoo Shin, Yunjin Nam, Seung Woo Suh, Jae Hyuk Yang","doi":"10.4055/cios24067","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>To evaluate the clinical impact of intraoperative tranexamic acid administration in minimizing intraoperative blood loss and transfusion requirements during minimally invasive scoliosis surgery (MISS).</p><p><strong>Methods: </strong>Consecutive data were collected from 97 patients with adolescent idiopathic scoliosis who underwent MISS between 2021 and 2023. Tranexamic acid was first introduced in June 2022. Surgical outcomes, complications, and blood parameters were compared between group A (no tranexamic acid) and group B (tranexamic acid).</p><p><strong>Results: </strong>Forty-three patients underwent surgery without intraoperative tranexamic acid (group A), and 54 underwent surgery with tranexamic acid (group B). Variables including age, height, weight, body mass index, hospital stay duration, Cobb angle, correction rate, curve type, fusion extent, and pre- and postoperative hemoglobin levels were not significantly different between the 2 groups (all <i>p</i> > 0.50). On average, 2.03 red blood cell (RBC) transfusions were administered. Group A required 2.6 units, whereas group B required 1.7 units, representing a significant reduction (<i>p</i> = 0.005). Postoperatively, an average of 0.5 RBC units were administered. Group A required 0.9 units, and group B required 0.3 units, with a significant difference (<i>p</i> = 0.001). No significant difference was found in the hemoglobin level between the day before surgery and postoperative days 1 and 4 (all <i>p</i> > 0.05). Significant differences were observed between the 2 groups in the estimated blood loss change (1,358 vs. 1,118 mL, <i>p</i> = 0.035) and Hemovac volume (1,063.26 vs. 910.65 mL, <i>p</i> = 0.002). Eleven patients in group A required thoracentesis or chest tube insertion after MISS, whereas those in Group B did not require invasive procedures.</p><p><strong>Conclusions: </strong>In MISS, tranexamic acid reduced blood transfusion needs, Hemovac volume, incidence and severity of hemothorax, and pleural effusion were associated with thoracoplasty.</p>","PeriodicalId":47648,"journal":{"name":"Clinics in Orthopedic Surgery","volume":"16 6","pages":"941-947"},"PeriodicalIF":1.9000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11604555/pdf/","citationCount":"0","resultStr":"{\"title\":\"Clinical Effects of Intraoperative Use of Tranexamic Acid in Minimally Invasive Scoliosis Surgery for Adolescent Idiopathic Scoliosis.\",\"authors\":\"Jungwook Lim, Rohit Akshay Kavishwar, Joungwoo Shin, Yunjin Nam, Seung Woo Suh, Jae Hyuk Yang\",\"doi\":\"10.4055/cios24067\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>To evaluate the clinical impact of intraoperative tranexamic acid administration in minimizing intraoperative blood loss and transfusion requirements during minimally invasive scoliosis surgery (MISS).</p><p><strong>Methods: </strong>Consecutive data were collected from 97 patients with adolescent idiopathic scoliosis who underwent MISS between 2021 and 2023. Tranexamic acid was first introduced in June 2022. Surgical outcomes, complications, and blood parameters were compared between group A (no tranexamic acid) and group B (tranexamic acid).</p><p><strong>Results: </strong>Forty-three patients underwent surgery without intraoperative tranexamic acid (group A), and 54 underwent surgery with tranexamic acid (group B). Variables including age, height, weight, body mass index, hospital stay duration, Cobb angle, correction rate, curve type, fusion extent, and pre- and postoperative hemoglobin levels were not significantly different between the 2 groups (all <i>p</i> > 0.50). On average, 2.03 red blood cell (RBC) transfusions were administered. Group A required 2.6 units, whereas group B required 1.7 units, representing a significant reduction (<i>p</i> = 0.005). Postoperatively, an average of 0.5 RBC units were administered. Group A required 0.9 units, and group B required 0.3 units, with a significant difference (<i>p</i> = 0.001). No significant difference was found in the hemoglobin level between the day before surgery and postoperative days 1 and 4 (all <i>p</i> > 0.05). Significant differences were observed between the 2 groups in the estimated blood loss change (1,358 vs. 1,118 mL, <i>p</i> = 0.035) and Hemovac volume (1,063.26 vs. 910.65 mL, <i>p</i> = 0.002). Eleven patients in group A required thoracentesis or chest tube insertion after MISS, whereas those in Group B did not require invasive procedures.</p><p><strong>Conclusions: </strong>In MISS, tranexamic acid reduced blood transfusion needs, Hemovac volume, incidence and severity of hemothorax, and pleural effusion were associated with thoracoplasty.</p>\",\"PeriodicalId\":47648,\"journal\":{\"name\":\"Clinics in Orthopedic Surgery\",\"volume\":\"16 6\",\"pages\":\"941-947\"},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2024-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11604555/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinics in Orthopedic Surgery\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.4055/cios24067\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/11/15 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"ORTHOPEDICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinics in Orthopedic Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4055/cios24067","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/11/15 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ORTHOPEDICS","Score":null,"Total":0}
引用次数: 0
摘要
背景:评估微创脊柱侧凸手术(MISS)中术中给药氨甲环酸对减少术中出血量和输血需求的临床影响。方法:收集2021年至2023年期间接受MISS治疗的97例青少年特发性脊柱侧凸患者的连续数据。氨甲环酸于2022年6月首次引入。比较A组(无氨甲环酸)和B组(氨甲环酸)的手术结果、并发症和血液参数。结果:A组手术中未加氨甲环酸43例,B组手术中加氨甲环酸54例。两组患者年龄、身高、体重、体质指数、住院时间、Cobb角、矫治率、曲线类型、融合程度、术后血红蛋白水平等变量差异无统计学意义(p < 0.05)。平均输注2.03个红细胞(RBC)。A组需要2.6个单位,而B组需要1.7个单位,显著减少(p = 0.005)。术后平均给予0.5个红细胞单位。A组需要量为0.9单位,B组需要量为0.3单位,差异有统计学意义(p = 0.001)。术前与术后第1、4天血红蛋白水平比较,差异无统计学意义(p < 0.05)。两组患者估计失血量变化(1358 vs 1118 mL, p = 0.035)和血量(1063.26 vs 910.65 mL, p = 0.002)差异有统计学意义。A组11例患者在MISS术后需要胸腔穿刺或胸管插入,而B组患者不需要侵入性手术。结论:在MISS患者中,氨甲环酸可减少输血需要量、血容量、血胸发生率和严重程度以及胸腔积液与胸腔成形术相关。
Clinical Effects of Intraoperative Use of Tranexamic Acid in Minimally Invasive Scoliosis Surgery for Adolescent Idiopathic Scoliosis.
Background: To evaluate the clinical impact of intraoperative tranexamic acid administration in minimizing intraoperative blood loss and transfusion requirements during minimally invasive scoliosis surgery (MISS).
Methods: Consecutive data were collected from 97 patients with adolescent idiopathic scoliosis who underwent MISS between 2021 and 2023. Tranexamic acid was first introduced in June 2022. Surgical outcomes, complications, and blood parameters were compared between group A (no tranexamic acid) and group B (tranexamic acid).
Results: Forty-three patients underwent surgery without intraoperative tranexamic acid (group A), and 54 underwent surgery with tranexamic acid (group B). Variables including age, height, weight, body mass index, hospital stay duration, Cobb angle, correction rate, curve type, fusion extent, and pre- and postoperative hemoglobin levels were not significantly different between the 2 groups (all p > 0.50). On average, 2.03 red blood cell (RBC) transfusions were administered. Group A required 2.6 units, whereas group B required 1.7 units, representing a significant reduction (p = 0.005). Postoperatively, an average of 0.5 RBC units were administered. Group A required 0.9 units, and group B required 0.3 units, with a significant difference (p = 0.001). No significant difference was found in the hemoglobin level between the day before surgery and postoperative days 1 and 4 (all p > 0.05). Significant differences were observed between the 2 groups in the estimated blood loss change (1,358 vs. 1,118 mL, p = 0.035) and Hemovac volume (1,063.26 vs. 910.65 mL, p = 0.002). Eleven patients in group A required thoracentesis or chest tube insertion after MISS, whereas those in Group B did not require invasive procedures.
Conclusions: In MISS, tranexamic acid reduced blood transfusion needs, Hemovac volume, incidence and severity of hemothorax, and pleural effusion were associated with thoracoplasty.